Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
 The compounds of formula I herein exhibit useful pharmacological activity and accordingly are incorporated into pharmaceutical compositions and used in the treatment of patients suffering from certain medical disorders. More specifically, they are inhibitors of the activity of Factor Xa. The present invention is directed to compounds of formula I, compositions containing compounds of formula I, and their use, for treating a patient suffering from, or subject to, a physiological condition which can be ameliorated by the administration of an inhibitor of the activity of Factor Xa. 
Aventis Pharma Deutschland GmbH
A A C A A C C A A A A C C C C C A A C
A61K A61K C07D A61K A61K C07D C07D A61K A61K A61P A61K C07D C07D C07D C07D C07D A61K A61K C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Yong Mi Yong Heinz W. Julian Jeffrey N. William R. Daniel M. Michael R.
Choi-Sledeski Gong Pauls Levell Barton Ewing Green Becker